Pencil Biosciences is a provider of gene-editing technology. It is developing an innovative gene modulation technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases. Founded in 2018, headquartered in Alderley Edge, United Kingdom. The company has raised $10.4M in funding at the seed stage. The team comprises 17 (Jun 30, 2026) employees. Pencil Biosciences operates in the Genomics sector. The company focuses on Gene Editing. Notable investors include o2h ventures, UK Innovation Science & Seed Fund, The GM&C Life Sciences Fund, o2h group, Catapult Ventures, Octopus Ventures, among others. The company has a team of 17 employees.
← All startups
Pencil Biosciences
SeedPencil Biosciences is a provider of gene-editing technology. It is developing an innovative gene modulation technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases. Founded in 2018, headquartered in Alderley Edge, United Kingdom. The company has raised $10.4M in funding at the seed stage. The team comprises 17 (Jun 30, 2026) employees.…
About
Business model
Genomics > Enabling Technologies > Technology Platforms > Gene Editing
Founders & team highlights
Serial Founder
Team background
College Wise > Imperial College London
Institutional investors
o2h venturesUK Innovation Science & Seed FundThe GM&C Life Sciences Fundo2h groupCatapult VenturesOctopus VenturesNorthern GritstoneMartlet CapitalSyndicate RoomFuture Planet CapitalPrism General PartnerJonathan MilnerMartin QuibellPaul RiverslathamJonathan Moore
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Backed by funds in our directory
🗂️ Explore Life Sciences investors — funds that write checks in this sector.